Prosecution Insights
Last updated: April 19, 2026

Merz Pharma GmbH & Co. Kgaa

6 pending office actions

Portfolio Summary

6
Total Pending OAs
3
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18620513 COMPOSITION COMPRISING BOTULINUM TOXIN FAN, LYNN Y 1759 Non-Final OA Mar 28, 2024
18043663 PLUNGER AND FINGER GRIP FOR A SYRINGE ASSEMBLY, METHOD FOR MAKING THEM, SYRINGE ASSEMBLY, KIT AND USE OF THE SAME PRICE, NATHAN R 3783 Non-Final OA Mar 01, 2023
17759420 INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION NGUYEN, NGOC-ANH THI 1615 Final Rejection Jul 25, 2022
17834232 HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY HUMPHREY, LOUISE WANG ZHIYING 1657 Final Rejection Jun 07, 2022
17431997 NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR GOUGH, TIFFANY MAUREEN 1651 Non-Final OA Aug 18, 2021
17255852 FATTY ACID-GRAFTED HYALURONIC ACID, DERMAL FILLER FORMULATIONS COMPRISING SAME, PROCESS FOR PREPARATION AND USE THEREOF MATTISON, LORI K 1619 Final Rejection Dec 23, 2020

Managing Merz Pharma GmbH & Co. Kgaa's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month